Diego Díaz-García, Medical Oncologist, CEO, and Founder of CánCare – Advanced Oncology Specialty, shared a post on X about a recent article by Jiarui Li et al. published in Nature Reviews Clinical Oncology:
“Optimizing CAR-T cell therapy for solid tumours.
Clinical progress is accelerating through better target selection, early manufacturing, locoregional delivery, and refined toxicity management. Translating CAR-T therapy beyond hematologic malignancies now depends on clinically driven optimization and robust response assessment.”
Title: Optimizing CAR T cell therapy for solid tumours: a clinical perspective
Authors: Jiarui Li, Chang Liu, Panpan Zhang, Lin Shen, Changsong Qi
Read the Full Article on Nature Reviews Clinical Oncology
More posts featuring Diego Díaz-García.
